Save your place

Sign in to WhoBought

Please try again later.

INmune Bio, Inc. (INMB) institutional ownership

Latest close $1.97 Jul 21, 2026
Market cap$68M 52-week range SectorHealthcare
Funds holding · Q1 2026
70
reported INMB position changes
Top owners · Q1 2026
No disclosed owners are available.
Institutional activity · Q1 2026
Activity unavailable N/A
39 buyers · 31 sellers

INmune Bio, Inc. (INMB) price and institutional activity

Dates

Q1 2026

$0 bought by 39 investors
AQR Capital Management LLCUBS Group AG +37 more
$0 sold by 31 investors
Dauntless Investment Group, LLCMorgan Stanley +29 more
Bought Sold Totals per quarter; hover a bar for the names.

INmune Bio, Inc. (INMB) institutional activity · 70

Investor Type Est. change Change Δ Own Date
AQR Capital Management LLC · Added
Change +250K Date Q1 2026
AQR Capital Management LLC Added· Q1 2026 +250K Q1 2026
UBS Group AG · Added
Change +193K Date Q1 2026
UBS Group AG Added· Q1 2026 +193K Q1 2026
Goldman Sachs Group Inc · Added
Change +175K Date Q1 2026
Goldman Sachs Group Inc Added· Q1 2026 +175K Q1 2026
Dauntless Investment Group, LLC · Reduced
Change −121K Date Q1 2026
Dauntless Investment Group, LLC Reduced· Q1 2026 −121K Q1 2026
Morgan Stanley · Reduced
Change −78K Date Q1 2026
Morgan Stanley Reduced· Q1 2026 −78K Q1 2026
Susquehanna International Group, LLP · Reduced
Change −57K Date Q1 2026
Susquehanna International Group, LLP Reduced· Q1 2026 −57K Q1 2026
State Street · Reduced
Change −56K Date Q1 2026
State Street Reduced· Q1 2026 −56K Q1 2026
Geode · Added
Change +53K Date Q1 2026
Geode Added· Q1 2026 +53K Q1 2026
Jain Global LLC · Exited
Change −42K Δ Own −100.0% Date Q1 2026
Jain Global LLC Exited· Q1 2026 −42K −100.0% Q1 2026
Xtx Topco Ltd · Reduced
Change −39K Date Q1 2026
Xtx Topco Ltd Reduced· Q1 2026 −39K Q1 2026
Jane Street Group, LLC · Added
Change +28K Date Q1 2026
Jane Street Group, LLC Added· Q1 2026 +28K Q1 2026
Bank of Montreal · Exited
Change −26K Δ Own −100.0% Date Q1 2026
Bank of Montreal Exited· Q1 2026 −26K −100.0% Q1 2026
Ieq Capital, LLC · New
Change +25K Date Q1 2026
Ieq Capital, LLC New· Q1 2026 +25K Q1 2026
Virtu Financial LLC · Exited
Change −20K Δ Own −100.0% Date Q1 2026
Virtu Financial LLC Exited· Q1 2026 −20K −100.0% Q1 2026
BlackRock · Reduced
Change −18K Date Q1 2026
BlackRock Reduced· Q1 2026 −18K Q1 2026
Data through Q1 2026 · filed Jun 3, 2026
15 of 70

Famous investor activity in INmune Bio, Inc. (INMB)

INmune Bio, Inc. (INMB) insider trading

Company insiders, action and economics first; trade and filed dates last.
Dates
Insider Title Type Price Qty Value Owned ΔOwn Trade date Filed date
Juda Scott · Director 2 operations $19K
Price $0.12–$1.40 Qty 0 Owned 15K Trade date Jul 2, 2026 Filed date Jul 7, 2026
Juda Scott Director 2 operations $0.12–$1.40 0 $19K 15K Jul 2, 2026 Jul 7, 2026
Lowdell Mark William · Officer 2 operations $9K
Price $0.12–$1.40 Qty 0 Owned 7K Trade date Jul 2, 2026 Filed date Jul 7, 2026
Lowdell Mark William Officer 2 operations $0.12–$1.40 0 $9K 7K Jul 2, 2026 Jul 7, 2026
Moss David J. · Director 2 operations $11K
Price $0.12–$1.40 Qty 0 Owned 9K Trade date Jul 2, 2026 Filed date Jul 7, 2026
Moss David J. Director 2 operations $0.12–$1.40 0 $11K 9K Jul 2, 2026 Jul 7, 2026
Moss David J. · Director, Officer Grant (A) 750K
Owned 750K Trade date Dec 1, 2025 Filed date Dec 2, 2025
Moss David J. Director, Officer Grant (A) 750K 750K Dec 1, 2025 Dec 2, 2025
Lowdell Mark William · Officer Grant (A) 600K
Owned 600K Trade date Dec 1, 2025 Filed date Dec 2, 2025
Lowdell Mark William Officer Grant (A) 600K 600K Dec 1, 2025 Dec 2, 2025
Ellspermann Cory Randall · Officer Grant (A) 300K
Owned 300K Trade date Dec 1, 2025 Filed date Dec 2, 2025
Ellspermann Cory Randall Officer Grant (A) 300K 300K Dec 1, 2025 Dec 2, 2025
Schroeder Timothy J. · Director Grant (A) 150K
Owned 150K Trade date Dec 1, 2025 Filed date Dec 2, 2025
Schroeder Timothy J. Director Grant (A) 150K 150K Dec 1, 2025 Dec 2, 2025
Juda Scott · Director Grant (A) 150K
Owned 150K Trade date Dec 1, 2025 Filed date Dec 2, 2025
Juda Scott Director Grant (A) 150K 150K Dec 1, 2025 Dec 2, 2025
Ganjei James Kelly · Director Grant (A) 150K
Owned 150K Trade date Dec 1, 2025 Filed date Dec 2, 2025
Ganjei James Kelly Director Grant (A) 150K 150K Dec 1, 2025 Dec 2, 2025
Allen Marcia · Director Grant (A) 150K
Owned 150K Trade date Dec 1, 2025 Filed date Dec 2, 2025
Allen Marcia Director Grant (A) 150K 150K Dec 1, 2025 Dec 2, 2025
Schroeder Timothy J. · Director 8 operations -366K
Owned 0 Trade date Nov 18, 2025 Filed date Nov 18, 2025
Schroeder Timothy J. Director 8 operations -366K 0 Nov 18, 2025 Nov 18, 2025
Schroeder Timothy J. · Director 8 operations 366K
Owned 108K Trade date Nov 18, 2025 Filed date Nov 18, 2025
Schroeder Timothy J. Director 8 operations 366K 108K Nov 18, 2025 Nov 18, 2025
Moss David J. · Director, Officer 8 operations -1.5M
Owned 0 Trade date Nov 18, 2025 Filed date Nov 18, 2025
Moss David J. Director, Officer 8 operations -1.5M 0 Nov 18, 2025 Nov 18, 2025
Moss David J. · Director, Officer 8 operations 1.5M
Owned 71K Trade date Nov 18, 2025 Filed date Nov 18, 2025
Moss David J. Director, Officer 8 operations 1.5M 71K Nov 18, 2025 Nov 18, 2025
Lowdell Mark William · Officer 5 operations -924K
Owned 0 Trade date Nov 18, 2025 Filed date Nov 18, 2025
Lowdell Mark William Officer 5 operations -924K 0 Nov 18, 2025 Nov 18, 2025
15 of 24
15 of 24 Sign in to continue to older insider transactions.

INmune Bio, Inc. (INMB) activist and large shareholders

Dates
Owner/Filer identity Shares reported % of shares outstanding Filing date
Xencor Inc 1.9M
% of shares outstanding 9.6% Filing date Oct 2, 2024
Xencor Inc 1.9M 9.6% Oct 2, 2024
Highbridge Capital Management, LLC 1.5M
% of shares outstanding 5.2% Filing date Aug 14, 2025
Highbridge Capital Management, LLC 1.5M 5.2% Aug 14, 2025
Cvi Investments, Inc. 1.4M
% of shares outstanding 4.9% Filing date Aug 14, 2025
Cvi Investments, Inc. 1.4M 4.9% Aug 14, 2025
Praetorian Pr LLC 771K
% of shares outstanding 2.9% Filing date Aug 14, 2025
Praetorian Pr LLC 771K 2.9% Aug 14, 2025
Altium Capital Management LP
% of shares outstanding 0.0% Filing date Feb 14, 2022
Altium Capital Management LP 0.0% Feb 14, 2022
5 of 5

INmune Bio, Inc. (INMB) ownership FAQ

Who owns INMB?

70 reporting institutions disclosed INMB position changes in the Q1 2026 snapshot.

How is institutional activity calculated?

For each manager, WhoBought compares accepted consecutive 13F share counts. Share change is current shares minus prior shares. Estimated dollar change is that signed share change multiplied by the split-adjusted quarter-mean close. The activity table on this page uses Q1 2026.

What are activist and large shareholder filings?

An investor crossing 5% of a share class generally files Schedule 13D for activist intent or Schedule 13G for a passive position. The technical form names appear here rather than in the activity rows.

Where does this data come from?

Ownership and institutional activity come from SEC Form 13F filings. Insider activity comes from SEC Form 4, and large-shareholder activity from SEC Schedules 13D and 13G. FMP supplies price data only. Company logos use the local verified Parqet cache with one shared fallback.

Why are ownership reports delayed?

Form 13F is a quarterly disclosure and is normally filed after the quarter ends. Every ownership and activity value therefore names its represented period; it is not presented as a live position.

How are missing table values shown?

A muted dash marks a missing table value. It means the filing omitted the value, comparable data is unavailable, or no prior position exists for comparison.